Response to letter to the editor: An in-depth look at the relationship between anti-diabetic drugs and Alzheimer's disease.

Autor: García-Zamora M; Research Group in Alzheimer Disease, Instituto de Investigación Sanitaria La Fe, Valencia, Spain; Cathedra DeCo MICOF-CEU UCH, University Cardenal Herrera-CEU, Valencia 46115, Spain., García-Lluch G; Research Group in Alzheimer Disease, Instituto de Investigación Sanitaria La Fe, Valencia, Spain; Cathedra DeCo MICOF-CEU UCH, University Cardenal Herrera-CEU, Valencia 46115, Spain., Moreno Royo L; Cathedra DeCo MICOF-CEU UCH, University Cardenal Herrera-CEU, Valencia 46115, Spain; Department of Pharmacy, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia 46115, Spain., Cháfer-Pericás C; Research Group in Alzheimer Disease, Instituto de Investigación Sanitaria La Fe, Valencia, Spain. Electronic address: m.consuelo.chafer@uv.es., Pardo Albiach J; Embedded Systems and Artificial Intelligence Group, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia 46115, Spain. Electronic address: juaparal@uchceu.es.
Jazyk: angličtina
Zdroj: Pharmacological research [Pharmacol Res] 2024 Oct; Vol. 208, pp. 107396. Date of Electronic Publication: 2024 Sep 05.
DOI: 10.1016/j.phrs.2024.107396
Abstrakt: Competing Interests: Declaration of Competing Interest None.
Databáze: MEDLINE
Externí odkaz: